Unilabs A/S Report issue

For profit Phase 1 Phase 2
Founded: Geneva Switzerland (1987)
Status: Acquired by Apax Partners (2016)

Organization Overview

First Clinical Trial
2019
NCT03883802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Unilabs | Unilabs A/S

Active Ingredients

Drugs in Phase 2 Trials (4)

fluorouracil (efudex) (1 trial)

foxy-5 (1 trial)

leucovorin (1 trial)

oxaliplatin (eloxatin) (1 trial)

Drugs in Phase 1 Trials (1)

Key: Unilabs A/S (0) Acquired (1)

sargramostim (leukine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5